HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis. - Wikidata - wikimedia - TriplyDB

HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

http://www.wikidata.org/entity/Q33641609

about

CD74 in Kidney Disease The use of flow cytometry to assess a novel drug efficacy in multiple sclerosis Sex-dependent treatment of chronic EAE with partial MHC class II constructs.Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke Tumor-associated and disease-associated autoantibody repertoires in healthy colostrum and maternal and newborn cord sera.HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection.Predicted structure of MIF/CD74 and RTL1000/CD74 complexes DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury.Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.Partial MHC class II constructs as novel immunomodulatory therapy for stroke.Role of Microglia in Neurological Disorders and Their Potentials as a Therapeutic Target.Invariant Chain Complexes and Clusters as Platforms for MIF Signaling.Solution-Phase Crosstalk and Regulatory Interactions Between Multipotent Adult Progenitor Cells and Peripheral Blood Mononuclear Cells Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis.Macrophage migration inhibitory factor (MIF) modulates trophic signaling through interaction with serine protease HTRA1.MIF and D-DT are potential disease severity modifiers in male MS subjects.DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury.Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.

P2860

Q26781254-99022EAE-5267-4A73-8684-9C13634FCE38 Q26824619-8E1CE7B7-43E3-453A-9317-39AD994506A3 Q33645392-D94A556C-9916-4024-9B69-4D49F862BAB8 Q34001070-C6D9BE20-F5FB-4E39-8087-D7C9959A162B Q35609259-0FA416B9-BEDD-494C-AD35-10417D2403D5 Q35782781-89235651-A420-452A-AE8C-C04F3E18C12B Q37595880-BA658508-7C57-4D04-AFBA-295CA2B1DE03 Q38743804-F3BFF007-7D04-4BE6-8702-D40A647189DA Q38791052-16AC0B40-5637-49A5-BC6B-CEB747A18F2B Q38988985-758B950E-C477-4DD8-9A3E-DAC2D87807BD Q39004244-BD76553F-4230-469D-8182-AF9176A0F12A Q39139156-166D556F-CD97-4717-9D3F-2D57852DED8F Q40400293-E68B945F-680A-40BF-8370-C2E08629E950 Q41732226-D09969C9-5140-443F-B6F2-88ED16A830E7 Q44918477-C7B87A36-905F-4A65-AFFC-CEAA8534CCA4 Q46234913-005C36E3-AE37-4807-8609-6FFF04BD4C7E Q48011437-DAA875DA-0091-4180-8EF9-4A8293F73E88 Q54941924-D5AF8C16-521D-4511-8E02-DEBBC56A4088

P2860

HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

http://www.wikidata.org/entity/Q33641609

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

HLA-DRα1 constructs block CD74 ...... autoimmune encephalomyelitis.

@ast

HLA-DRα1 constructs block CD74 ...... autoimmune encephalomyelitis.

@en

type

label

HLA-DRα1 constructs block CD74 ...... autoimmune encephalomyelitis.

@ast

HLA-DRα1 constructs block CD74 ...... autoimmune encephalomyelitis.

@en

prefLabel

HLA-DRα1 constructs block CD74 ...... autoimmune encephalomyelitis.

@ast

HLA-DRα1 constructs block CD74 ...... autoimmune encephalomyelitis.

@en

P1433

Q33641609-6F76AD18-4D12-49CF-9C63-803728E3B570

P1476

Q33641609-CF95E585-D82B-45DC-853E-17FDA375A586

P2093

Q33641609-03CF2AE6-51A7-4207-8846-5B95F5EE9ED9

Q33641609-3E146A6F-3D84-40BC-98EC-E325F26F6DC3

Q33641609-556A7DA6-2B4A-4606-874D-32A2FC177407

Q33641609-70403201-460A-477D-8ED5-D5069C0A0297

Q33641609-97B2780C-A2D7-4F71-A9BE-455C368DE59D

Q33641609-A7232A20-7703-47CF-912F-AF19811C5972

Q33641609-CA15CC5E-D08D-461A-B898-5117070FE4BC

Q33641609-CAEE7377-71DF-4DA5-AAE2-AC93681C7E6A

Q33641609-D620DA36-58AD-423A-ADBC-5212DD2153DB

P2860

Q33641609-01CF6F99-C99F-4F27-80D4-AAEA22CED54C

Q33641609-0C770401-48B5-4B3C-B426-044D4588CA47

Q33641609-0E0AAF23-D75A-4A6A-A5FD-A3E05EA27B00

Q33641609-10C4D5BF-A966-40D8-9C04-1B7EBC1DFDC5

Q33641609-1F3A3966-C9BF-49E1-9631-E02353C5257A

Q33641609-2800AAB0-1732-48FE-8E36-5CC631F7379D

Q33641609-2EA2B2BB-4FBE-4A65-84E5-9F02AB357BB5

Q33641609-3A3575E9-1018-402C-902E-D8E31158C7F0

Q33641609-3C0282A4-D593-4133-987F-1E3D8D6D7F0E

Q33641609-3E8AF47C-68D7-47FD-9B4F-0CC21A8AF6DA

P304

Q33641609-8F36EEEE-4674-4D6E-8969-D84364B2D22A

P31

Q33641609-2A79061B-D4F4-42F1-800D-AED590CC17CB

P356

Q33641609-F058839E-B972-40A7-8E5B-96E294BC0181

P407

Q33641609-91932C1C-6D66-47E6-A413-5225B64A6D50

P433

Q33641609-191F6AEA-D814-4ECE-B960-096DCAA5615C

P478

Q33641609-CAFB1AF2-0C74-4BEA-AA7E-33F57BB78860

P50

Q33641609-1AE0E2A9-DF5E-48EA-B7E7-13A90551EC4F

Q33641609-5360EC9B-E4D3-440A-BAD5-60F82C523C94

P577

Q33641609-AADFB3D4-C007-4B29-9930-A98E59E3EBD0

P5875

Q33641609-B75D8DB0-239F-4CA9-8224-98E04C5D1610

P698

Q33641609-2D47D0EF-4428-4D3D-B6DF-F21930DBB596

P932

Q33641609-559D202C-9932-4FE7-AED4-C55732EFF6A4

P356

JIMMUNOL.1303118

P1433

Journal of Immunology

P1476

HLA-DRα1 constructs block CD74 ...... autoimmune encephalomyelitis.

@en

P2093

Arthur A Vandenbark

http://www.w3.org/2001/XMLSchema#string

Gil Benedek

http://www.w3.org/2001/XMLSchema#string

Gregory G Burrows

http://www.w3.org/2001/XMLSchema#string

Halina Offner

http://www.w3.org/2001/XMLSchema#string

Jeffery L Mooney

http://www.w3.org/2001/XMLSchema#string

Nerri Duvshani

http://www.w3.org/2001/XMLSchema#string

Roberto Meza-Romero

http://www.w3.org/2001/XMLSchema#string

Xiaolin Yu

http://www.w3.org/2001/XMLSchema#string

Yoram Reiter

http://www.w3.org/2001/XMLSchema#string

P2860

MIF signal transduction initiated by binding to CD74

CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex

An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules

A functional heteromeric MIF receptor formed by CD74 and CXCR4

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

Bidirectional binding of invariant chain peptides to an MHC class II molecule

Crystal Structure of the HLA-DM–HLA-DR1 Complex Defines Mechanisms for Rapid Peptide Selection

Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding

P304

4164-4173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1303118

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

192

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261222008

http://www.w3.org/2001/XMLSchema#string

P698

24683185

http://www.w3.org/2001/XMLSchema#string

P932

4028955

http://www.w3.org/2001/XMLSchema#string